Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 8
Submit an article Journal homepage
985
Views
12
CrossRef citations to date
0
Altmetric
Cardiovascular

Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view

Lin XieSTATinMED Research, Ann Arbor, MI, USA; Correspondence[email protected]
,
Lien VoBristol-Myers Squibb, New York, NY, USA;
,
Allison KeshishianSTATinMED Research, Ann Arbor, MI, USA;
,
Kwanza PricePfizer Inc., New York, NY, USA;
,
Prianka SinghBristol-Myers Squibb, New York, NY, USA;
,
Jack MardekianPfizer Inc., New York, NY, USA;
,
Amanda BrunoBristol-Myers Squibb, New York, NY, USA;
,
Onur BaserSTATinMED Research, Ann Arbor, MI, USA; ;Columbia University, New York, NY, USA
,
Jully KimBristol-Myers Squibb, New York, NY, USA;
,
Wilson TanPfizer Inc., New York, NY, USA;
&
Jeffrey TrocioPfizer Inc., New York, NY, USA;
show all
Pages 769-776 | Received 24 Nov 2015, Accepted 29 Feb 2016, Published online: 24 Apr 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alpesh Amin, Allison Keshishian, Lien Vo, Qisu Zhang, Oluwaseyi Dina, Chad Patel, Kevin Odell & Jeffrey Trocio. (2018) Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan. Journal of Medical Economics 21:3, pages 244-253.
Read now
M. S. Jacobs, M. W. J. van Leent, R. G. Tieleman, F. G. A. Jansman, Q. Cao, M. J. Postma & M. van Hulst. (2017) Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands. Journal of Medical Economics 20:12, pages 1231-1236.
Read now
Jay Lin, Jeffrey Trocio, Kiran Gupta, Jack Mardekian, Melissa Lingohr-Smith, Brandy Menges, Min You & Anagha Nadkarni. (2017) Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting. Journal of Medical Economics 20:9, pages 952-961.
Read now

Articles from other publishers (9)

Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, Jennifer D. Guo, Rajesh Mallampati, Mauricio Ferri, Cristina Russ, Birol Emir, Matthew Cato, Huseyin Yuce & Jonathan C. Hsu. (2022) Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database. PLOS ONE 17:2, pages e0263903.
Crossref
Alpesh AminAllison KeshishianJeffrey TrocioOluwaseyi DinaHannah LeLisa RosenblattXianchen LiuJack MardekianQisu ZhangOnur BaserAnagha NadkarniLien Vo. (2020) A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy 26:5, pages 639-651.
Crossref
Ruijin Qiu, Jiayuan Hu, Ya Huang, Songjie Han, Changming Zhong, Min Li, Tianmai He, Yiyi Lin, Manke Guan, Jing Chen & Hongcai Shang. (2019) Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review. BMJ Open 9:8, pages e028803.
Crossref
Kiran GuptaJeffrey TrocioAllison KeshishianQisu ZhangOluwaseyi DinaJack MardekianLisa RosenblattXianchen LiuShalini HedeAnagha NadkarniTom Shank. (2018) Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population. Journal of Managed Care & Specialty Pharmacy 24:11, pages 1116-1127.
Crossref
Alpesh AminAllison KeshishianJeffrey TrocioOluwaseyi DinaHannah LeLisa RosenblattXianchen LiuJack MardekianQisu ZhangOnur BaserAnagha NadkarniLien Vo. (2018) A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy 24:9, pages 911-920.
Crossref
Lara M. Groetzinger, Taylor J. Miller, Ryan M. Rivosecchi, Roy E. Smith, Mark T. Gladwin & Belinda N. Rivera-Lebron. (2018) Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis. Clinical and Applied Thrombosis/Hemostasis 24:6, pages 908-913.
Crossref
Catherine A Saint, Michelle R Castelli, Andrew J Crannage, Zachary A Stacy & Erin K Hennessey. (2017) Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism. SAGE Open Medicine 5, pages 205031211771962.
Crossref
Steven DeitelzweigXuemei LuoKiran GuptaJeffrey TrocioJack MardekianTammy CurticeMelissa Lingohr-SmithBrandy MengesJay Lin. (2017) Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy 23:11, pages 1191-1201.
Crossref
Erin R. Weeda, W. Frank Peacock, Gregory J. Fermann, Christopher W. Baugh, Philip S. Wells, Veronica Ashton, Concetta Crivera, Peter Wildgoose, Jeff R. Schein & Craig I. Coleman. (2017) Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. International Journal of Clinical Practice 71:1, pages e12915.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.